Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic

The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and pre-existing cardiovascular disease have an increased risk of severe di...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology Vol. 75; no. 18; p. 2352
Main Authors: Driggin, Elissa, Madhavan, Mahesh V, Bikdeli, Behnood, Chuich, Taylor, Laracy, Justin, Biondi-Zoccai, Giuseppe, Brown, Tyler S, Der Nigoghossian, Caroline, Zidar, David A, Haythe, Jennifer, Brodie, Daniel, Beckman, Joshua A, Kirtane, Ajay J, Stone, Gregg W, Krumholz, Harlan M, Parikh, Sahil A
Format: Journal Article
Language:English
Published: United States 12.05.2020
Subjects:
Arrhythmias, Cardiac - complications
Arrhythmias, Cardiac - virology
Betacoronavirus
Coronavirus Infections - complications
Coronavirus Infections - epidemiology
Coronavirus Infections - therapy
COVID-19
Health Personnel
Heart Diseases - complications
Heart Diseases - virology
Humans
Myocarditis - complications
Myocarditis - virology
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
Risk Factors
SARS-CoV-2
Triage
cardiovascular therapy
coronavirus
health system
ISSN:1558-3597, 1558-3597
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and pre-existing cardiovascular disease have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects. Fourth, the response to COVID-19 can compromise the rapid triage of non-COVID-19 patients with cardiovascular conditions. Finally, the provision of cardiovascular care may place health care workers in a position of vulnerability as they become hosts or vectors of virus transmission. We hereby review the peer-reviewed and pre-print reports pertaining to cardiovascular considerations related to COVID-19 and highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1558-3597
1558-3597
DOI:10.1016/j.jacc.2020.03.031